Clinical Handbook of Psychotropic Drugs for Children and Adolescents

Publication Year: 2018

Edition: 4th Ed.

Authors/Editor: Elbe, Dean; Black, Tyler R.; McGrane, Ian R.; Procyshyn, Ric M.

Publisher: Hogrefe Publishing GmbH

ISBN: 978-0-88-937550-5

Doody's Star Rating®: Score: 89

Doody Core Title:

  • Score: 2.33 (Psychiatric)
Request more information

Description

Quick and comprehensive information on psychotropic drugs for children and adolescents.

The Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.

  • Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
  • Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more – all you need to know for each class of drug
  • Potential interactions and side effects summarized in comparison charts
  • With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
  • Clearly written patient and caregiver information sheets

This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.

New in this edition:

  • Drugs for ADHD thoroughly revised and updated
  • Antipsychotics with many changes and additions, including fully revised lab tests/monitoring
  • Antidepressants fully revised, including new sections on irreversible MAO-B inhibitor and serotonin modulator and stimulator (SMS), revised frequency of adverse effects table and switching strategies recommendations
  • Hypnotics completely revised
  • Mood stabilizers fully revised and a new toxicity comparison table added
  • Drugs of abuse and treatment of substance use disorders comprehensively revised
  • New unapproved treatments with significant updates, including: anti-inflammatories and NMDA agents in anxiety/OCD, cannabis use disorder, and irritability of autism
  • New agents include: Third generation antipsychotics brexpiprazole and cariprazine, orexin receptor antagonist suvorexant, selective melatonin agonist tasimelteon, serotonin modulator and stimulator vortioxetine
  • New formulations and trade names include: Adasuve, Alprazolam Intensol, Aptensio XR, Aristada, Belbuca, Belsomra, Brintellix, Bunavail, Cotempla XR-ODT, Dyanavel XR, Eldepryl, EMSAM, Evekeo, Hemangeol, Hetlioz, Innopran XL, Invega Trinza, Khedezla, Metadol-D, Mydayis, NyQuil, Quillichew ER, Quillivant XR, Rexulti, Tegretol (liquid), Trintellix, Versacloz, Vraylar, Zelapar, Zenzedi

Details

Platform: Ovid
Publisher: Hogrefe Publishing GmbH
Product Type: Book
Author/Editor: Elbe, Dean; Black, Tyler R.; McGrane, Ian R.; Procyshyn, Ric M.
ISBN: 978-0-88-937550-5
Language: English
Edition: 4th Ed.
Pages: 396
Year: 2018
Doody's Star Rating®: Score: 89

Doody Core Title:
Score:
  • 2.33 (Psychiatric)

Collections

Clinical Handbook of Psychotropic Drugs for Children and Adolescents

Resources of the Month

PsycBOOKS®

PsycBooks
 

Test Drive

Evidence Based Medicine Reviews

EBMR


Test Drive

The Journal of Urology®

JBJS


Test Drive

JBJS Journal of Orthopaedics for Physician Assistants

JBJS JOPA


Test Drive

Loading